KaushalParikhMD

Oncology • Rochester, MN

Hematologic Oncology

Physician

Join to view full profile

Dr. Parikh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Parikh's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2018 - 2019
Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Westchester Medical CenterResidency, Internal Medicine, 2012 - 2015
Topiwala National Medical CollegeClass of 2011

Certifications & Licensure

MN State Medical License 2018 - 2025
NJ State Medical License 2019 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

8 citations
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort St...
Amin H Nassar, So Yeon Kim, Jacqueline V Aredo, Jamie Feng, Frances Shepherd
Journal of Thoracic Oncology. 2024-06-01
12 citations
Oncogenic alterations in advanced NSCLC: a molecular super-highway.
Alex Friedlaender, Maurice Perol, Giuseppe Luigi Banna, Kaushal Parikh, Alfredo Addeo
Biomarker Research. 2024-02-12
5 citations
Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review.
Maxime Borgeaud, Kaushal Parikh, Giuseppe Luigi Banna, Floryane Kim, Timothée Olivier
Journal of Thoracic Oncology. 2024-07-01

Lectures

Low nationwide utilization of adjuvant chemotherapy (AC) in elderly patients with localized non-small cell lung cancer (NSCLC).
2019 ASCO Annual Meeting - 6/1/2019
Overestimation of tumor mutational burden (TMB) using algorithms compared to germline subtraction.
2019 ASCO Annual Meeting - 6/1/2019
A nationwide analysis of palliative care service utilization in hospitalized metastatic cancer patients.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018